American Journal of Surgical Pathology March, 2007 David J. Dabbs, MD, Rohit Bhargava, MD, and Mamatha Chivukula, MD Int. 簡聖軒 Lobular Versus Ductal Breast.

Slides:



Advertisements
Similar presentations
Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A
Advertisements

Instructions and Reporting Requirements Module 2 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
DISEASES OF THE BREAST IN ACCRA Solomon E. Quayson MSc(Lond).,DIC.,FWACP.
HISTOLOGICAL QUALITY CONTROL OF FROZEN SAMPLES USING MATCHING FFPE TISSUE – PRELIMINARY RESULTS OF OUR INSTITUTIONAL BIOBANK E. Mattioli, E. Foglia Manzillo,
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Introduction to Neoplasia
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
COMPUTATIONAL INTELLIGENCE FOR THE DETECTION AND CLASSIFICATION OF MALIGNANT LESIONS IN SCREENING MAMMOGRAPHY DATA E. Panourgias,
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis
Pathology Journal Reading
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
P63 Expression in Breast Cancer
USE OF P63 IN ASSESSING MIMICS OF PROSTATIC ADENOCARCINOMA DR. A. T. ATANDA, BAYERO UNIVERSITY/AMINU KANO TEACHING HOSP. KANO.
Procedures used by CHTN
Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR.
Moving Toward Personalized Treatment for Gastric Cancer: Role of HER2 Testing Frédérique Penault-Llorca, MD, PhD Professor of Pathology Centre Jean Perrin.
1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Ductal Carcinoma in situ
Proliferative Epithelial lesions of the Breast
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Histological Stains. Tissue Processing To some extent, light-level (as opposed to e.m.- level) histology is a lost art, especially if one is interested.
Surgery Journal Club By : Ahmad Zahmatkesh Mohammadreza Nazemian.
Marion C.W. Henry, MD Yale University
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Multiple adenocarcinomas and synchronous leiomyosarcoma of the colon: a case report M.C. De Nisi, C.Maggiore, C.Minacci, M.Stumpo, M.L. Palmeri, L. Pergola,
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
Comparing the Positive Effect of Vitamin E and Flouxetine in the Treatment of Hot Flashes in Breast Cancer Patients. Comparing the Positive Effect of.
Session 5. Case Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided.
1 Preclinical-Bench Testing II Using Human Observers to Objectively Measure and Evaluate Imaging Performance of Digital WSI Systems Max Robinowitz, MD.
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Objectives Discuss the history of breast cancer. Describe the pathology of breast cancer and list significant tumor markers. Differentiate IHC testing.
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
Pathology Reports Nicole Draper, MD.
ANNUAL SLIDE SEMINAR June Bratislava Slovakia B. Fredrik Petersson MD, PhD Department of Pathology, Karolinska University Hospital Stockholm.
Small....but lethal.
Effect of 21-Gene Reverse- Transcriptase Polymerase Chain Reaction Assay on Treatment Recommendations in Patients with Lymph Node-Positive and Estrogen.
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
INTESTINAL DIFFERENTIATION IN PULMONARY ADENOCARCINOMA Paul Theunissen, MD, PhD, Nick van Rodijnen, Dept. of pathology, Atrium Medisch Centrum, Heerlen,
Use of Histone Deacetylase 8 (HDAC8), a New Marker of Smooth Muscle Differentiation, in the Classification of Mesenchymal Tumors of the Uterus Laurence.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
British/ Arab School of Pathology, June 2008 Slide Seminars.
Pathology.
부산대학교병원 김 주 연 2012 년 세포병리학회 가을학술대회 월례집담회.  F/52  Past history : 03’ left breast operation, on follow up  Lower abdominal pain (12’ April)  Physical.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.
ATYPICAL CARCINOID TUMOUR OF THE LARYNX. A CASE REPORT. S.Squillaci (1) R.Marchione (1) C.Spairani (1) M.Bisceglia (2) Department of Pathology, Hospital.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
A Signet Ring Cell Tumor of The Ovary, Diagnosed After Treatment of Hodgkin lymphoma The First Case Of The Literature Dr. Sakir Volkan Erdogan Bakirkoy.
Woo Cheal Cho MD1, Fabiola Balarezo, MD1
Multistep model of breast cancer progression
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Pre neoplastic lesions
Table 2. Association between histology grade, lymph node status,
Wijendra Senarathne1, Peggy Gates1, Semir Vranic2, Zoran Gatalica1
SNOMED CT and Surgical Pathology
Thomas Kirchner, Thomas Brabletz  The American Journal of Pathology 
SOX10 Is a Novel Sensitive Diagnostic Marker for Adenoid Cystic Carcinoma of the Breast: Immunohistochemical Analysis of Adenoid Cystic Carcinoma Chen.
Preinvasive Neoplasia in the Stomach: Diagnosis and Treatment
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Handling and Evaluation of Breast Cancer Biopsy
Marion C.W. Henry, MD Yale University
(Handling and Evaluation of Breast Cancer Biopsy)
Presentation transcript:

American Journal of Surgical Pathology March, 2007 David J. Dabbs, MD, Rohit Bhargava, MD, and Mamatha Chivukula, MD Int. 簡聖軒 Lobular Versus Ductal Breast Neoplasms The Diagnostic Utility of P120 Catenin

Introduction  The diagnostic discrimination of ductal versus lobular neoplasms is important in several circumstances for therapeutic reasons.  Diagnostic reproducibility of lobular versus ductal lesions, based on histology alone, is less than optimal.  It is important to correctly diagnose the specific types of breast neoplasia so that appropriate risk assessment and prognostic and predictive tests will be performed and appropriate therapies instituted.

Introduction  The broad categories of ductal and lobular neoplasias of the breast represent the majority of important breast lesions, but there are striking differences in morphology, molecular alterations, and treatment strategies for each category.  The proper distinction between atypical lobular hyperplasia, lobular carcinoma in situ and low- grade ductal carcinoma in situ is critical for patient management.

Introduction  Low-grade ductal carcinoma in situ Surgical excision with proper margins and perhaps radiation therapy and continuous follow-up.  Lobular carcinomas I : Lumpectomy + ALND + C/T II, III : Mastectomy + ALND + C/T IV : C/T + selective H/T

Introduction  The pathologic diagnosis of metastatic breast carcinoma remains a challenge even today.  A plethora of antibodies in the diagnostic armamentarium, and less than a handful of antibodies are useful in identifying breast carcinomas in metastatic sites. a. Gross cystic disease fluid protein fraction 15 (GCDFP- 15) b. Hormone receptors estrogen and progesterone (ER/PR) c. Cytokeratin 7 (CK7) d. Mammaglobin antibody

Introduction  In the breast, E-cadherin is useful to distinguish between ductal and lobular neoplasia. a. Ductal : Cell membrane, E-cadherin (+) b. Lobular : E-cadherin  E-cadherin is present in most epithelia, and therefore is not specific for diagnostic use in the setting of metastatic carcinomas.

Introduction The E-cadherin complex is composed of the transmembrane E-cadherin protein and α,β,γ, and P120 catenins (ctn) which anchor the E-cadherin protein to the cytoplasmic actin filaments.

Introduction  We and others have recently discovered a characteristic cytoplasmic redistribution of P120ctn in lobular neoplasia. a. Ductal : dominant membrane immunostaining pattern of P120ctn b. Lobular : diffuse cytoplasmic P120ctn immunostaining pattern

Introduction  In this study, we survey neoplastic ductal and lobular lesions of the breast with P120ctn to determine its utility for the surgical pathologist.  In addition, we survey a broad variety of other carcinomas to determine whether the P120ctn cytoplasmic immunostaining pattern seen in lobular neoplasia may be useful in the diagnosis of metastatic lobular carcinoma.

Method  Formalin-fixed ; Paraffin-embedded  Invasive lobular carcinoma : 64 cases Invasive ductal carcinoma : 62 cases  These cases were retrieved from the archives of the Department of Pathology, Magee-Women’s Hospital.  For the study of neoplastic breast lesions, each case was examined by a hematoxylin/eosin section, E-cadherin, and P120ctn independently.

Method  Each tumor was classified as lobular or ductal on the basis of standard histologic criteria.  Cell membrane immunostaining for E-cadherin was considered to be a ductal immunophenotype. Complete lack of the membrane immunostaining was considered to be a lobular immunophenotype.  Each case was independently reviewed for the pattern of cellular immunostaining for P120ctn.

Method  Ductal immunophenotype : Cell membrane immunostaining for P120ctn of any intensity, without cytoplasmic immunostaining.  Lobular immunophenotype : Diffuse cytoplasmic immunostaining without any appreciable cell membrane accentuation for P120ctn.

Method  To survey a broad array of carcinomas for the presence of cytoplasmic P120ctn immunostaining, tissue microarrays (TMA) were used.  TMAs were fixed in formalin, paraffin embedded and subject to the same immunostaining procedure as the breast tissue sections described above.  A summary of the TMA components with detailed immunostaining scores is listed in Table 1.

Method  P120ctn Stain 1. C : Cytoplasmic 2. C+M : Cytoplasmic and Membrane 3. M : Membrane  Tissue microarrays (TMA) 1. Weak: 1+ staining in any percentage of cells or 2+ staining in <10% of cells 2. Moderate: 2+staining in >10% of cells or 3+ staining in <10% of cells 3. Strong: 3+ staining in >10% of cells

Result  Lobular neoplasia There was a lack of E-cadherin membrane staining and there was a diffuse, intense cytoplasmic P120ctn immunostaining.  Ductal carcinomas Distinct membrane accentuation pattern of P120ctn was noted.

A.Invasive lobular carcinoma, hematoxylin/eosin B. P120ctn: invasive lobular carcinoma with diffuse cytoplasmic stain

C. Comparison of membranous P120ctn staining in normal duct to the cytoplasmiconly staining of lobular carcinoma D. Negative E-cadherin of the same case in (C), membranous pattern in normal duct

Result  P120ctn was a diagnostic aid in challenging case.  Sometimes, the immunostaining of myoepithelial cells with E-cadherin in lobular neoplasia may be a challenge to interpret.

Duct epithelial hyperplasia Or Atypical lobular hyperplasia

P120ctn shows intense cytoplasmic immunostaining of ALH cells appearing in the lobule. Membranous immunostaining

E-cadherin result of this same case is less conspicuous, but shows lack of membrane immunostaining of ALH cells. Myoepithelial cells are stained with E-cadherin. Shows immunostaining of myoepithelial cells with smooth muscle myosin heavy chain in the section adjacent to (E).

Low-grade ductal neoplasia or Lobular neoplasia with microcalcification?

P120ctn confirms lobular neoplasia with characteristic intense, diffuse cytoplasmic immunostaining.

Result  The E-cadherin and P120ctn patterns defined the ductal or lobular types.  Classic and pleomorphic variants of lobular carcinoma showed identical patterns for P120ctn

Pleomorphic variant of lobular carcinoma, hematoxylin/eosin. Diffuse cytoplasmic pattern for P120ctn.

Result  In the TMA survey, some rectal (9/63) and gastric (3/72) adenocarcinomas a. Dominant cytoplasmic P120ctn immunostaining pattern b. Similar to lobular neoplasms.  These rectal and gastric carcinomas were all of the diffusely infiltrating pattern with various degrees of mucinous signet ring cells, mimicking the appearance of lobular carcinoma  None of the other carcinomas demonstrated the exclusive diffuse cytoplasmic P120ctn immunostaining pattern.

Rectal carcinoma Gastric carcinoma 1.The rectal (A) and gastric (B) carcinomas of the diffusely infiltrating pattern mimic the appearance of lobular carcinoma 2.All had strong cytoplasmic P120ctn.

Discussion  Sarrio et al demonstrated that P120ctn had a cytoplasmic localization in ALH, LCIS, and invasive lobular carcinoma.  We also documented P120ctn cytoplasmic immunostaining in ALH, and found it to be somewhat easier to interpret than negative E- cadherin in early cases of ALH where duct epithelial hyperplasia was in the differential diagnosis.

Discussion  Nearly 90% of diffusely infiltrating gastric carcinomas showed cytoplasmic P120ctn whereas half of these cases also lost membrane P120ctn immunostaining.  A similar distribution of E-cadherin and P120ctn was seen in colorectal carcinomas.  Skoudy et al using fresh frozen tissue and a different P120ctn antibody, found less than half of colon adenocarcinoma cells had cytoplasmic positivity.

Discussion  In our study, the diffusely infiltrating rectal and gastric tumors which morphologically mimic invasive lobular carcinoma, also demonstrated diffuse cytoplasmic immunostaining for P120ctn in every cell.  P120ctn alone would not be useful to diagnostically separate lobular carcinoma from these diffuse-type rectal and gastric carcinomas.  P120ctn may be a useful part of a diagnostic panel of antibodies in the workup of a case in which breast carcinoma is in the differential diagnosis.  An immunopanel that includes gastrointestinal markers and estrogen receptor would be necessary to definitively make this distinction.

Discussion  A diffuse strong cytoplasmic P120 immunostaining pattern in a dyscohesive carcinoma should raise the possibility of lobular breast carcinoma.  Additional antibodies that would be useful to distinguish lobular carcinoma from the diffusely infiltrating variants of rectal and gastric carcinoma would include estrogen receptor, GCDFP-15, mammaglobin, cytokeratins 7 and 20, and CDX-2 transcription factor.

Thank you